Cargando…
Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma
BACKGROUND: The bone marrow microenvironment provides an optimal substrate for multiple myeloma (MM) initiation and progression. The soluble component of MM niche is dynamic with the disease states of MM. We formerly employed proteomic profiling to construct a MM model. Four peptides constituting th...
Autores principales: | Bai, Ju, Yang, Yun, Wang, Jianli, Zhang, Lei, Wang, Fangxia, He, Aili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477722/ https://www.ncbi.nlm.nih.gov/pubmed/31043929 http://dx.doi.org/10.1186/s12014-019-9238-0 |
Ejemplares similares
-
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
por: Bai, Ju, et al.
Publicado: (2013) -
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2014) -
Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2020) -
CD138(-) multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient
por: Wu, Dong, et al.
Publicado: (2020) -
Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma
por: Chen, Jie, et al.
Publicado: (2015)